Facebook Linkedin Mail X Youtube
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe
Search
Facebook Linkedin Mail X Youtube
Cardiovascular News Cardiovascular News
Cardiovascular News Cardiovascular News
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe

Tag: ticagrelor

ACC.25: Bentracimab can reverse bleeding complications linked to ticagrelor

29th March 2025
An investigational mo...

ESC 2019: Prasugrel bests ticagrelor for the management of acute coronary syndromes

1st September 2019
Stefanie Schüpke (Deu...

PhaseBio receives FDA breakthrough therapy designation for PB2452 for the reversal of the antiplatelet activity of ticagrelor

11th April 2019
PhaseBio Pharmaceuticals,...

Ticagrelor significantly reduces the risk of MACE in myocardial infraction patients with multivessel disease

7th February 2018
A new subanalysis of ...

Orodispersible tablets of ticagrelor now available in the UK

20th July 2017
AstraZeneca has announced...

NICE recommends dual antiplatelet therapy with ticagrelor and aspirin

4th November 2016
The National Institute of...

ESC 2016: First head-to-head comparisons of prasugrel and ticagrelor shows no significant differences

9th September 2016
The initial results o...
Cardiovascular News

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com


BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy
Facebook Linkedin Mail X Youtube